Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PLENDIL

FELODIPINE

Standard Dose
10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview PLENDIL is listed in Drugs@FDA under application 019834 (NDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient FELODIPINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ASTRAZENECA Submission history Latest submission status date: 2012-10-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview PLENDIL is listed in Drugs@FDA under application 019834 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient FELODIPINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ASTRAZENECA Submission history Latest submission status date: 2012-10-31 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.
PLENDIL (FELODIPINE) | Drug Monograph | MedicHelpline